Smiths Group PLC Appoint new CEO for Smiths Medical

Smiths Group Plc

Smiths Group plc (LON: SMIN) has today announced the appointment of JehanZeb Noor as Chief Executive Officer of Smiths Medical. JehanZeb will be part of Smiths Group’s Executive Committee and report to Andy Reynolds Smith, CEO of Smiths Group plc.

JehanZeb will take up the role on 1 July 2019 and will oversee the separation of Smiths Medical, which is expected to be completed during the first half of CY2020.

JehanZeb joins from Amcor Flexibles Inc., where he led the Healthcare North America business and Global Sales for Medical. Amcor is a specialist producer of sterile packaging for the global medical device and pharmaceuticals industries. During his three-year tenure at Amcor he drove a significant improvement in margin and revenue growth and led the integration of a major acquisition. Prior to joining Amcor, JehanZeb was a Partner at McKinsey & Company where he served for 9 years. He has a deep understanding of the MedTech supply chain, operations, distribution, product development and regulatory approval processes. JehanZeb holds a BSc in Finance and a BSc and MSc in Mechanical Engineering from the Massachusetts Institute of Technology.

Andy Reynolds Smith, Chief Executive of Smiths Group plc, commented:

“I look forward to working with JehanZeb as we continue building a strong, sustainable future for Smiths Medical and progress the separation of the business from Smiths Group. I am confident that JehanZeb’s intimate understanding of the MedTech industry combined with his strong track record of effective leadership, delivering growth and enhanced performance will make him a great success.”

JehanZeb Noor, Smiths Medical Chief Executive Officer Designate, commented:

“Smiths Medical is an industry leader, offering high quality specialised medical devices across the globe with significant investment in new products. The company will begin an exciting new chapter when it separates from the wider Group and I’m looking forward to the opportunity to join the team and lead the journey ahead to achieve our full potential, while serving a life saving mission.”

Share on:

Latest Company News

Smiths Group appoints Laurence Mulliez as Independent Non-executive Director

Smiths has appointed Laurence Mulliez as an independent Non-executive Director, effective 1 September 2026. She brings extensive leadership, governance and board experience across global industrial and energy businesses.

Smiths lowers FY2026 revenue guidance after Middle East disruption

Smiths reported flat organic revenue growth in Q3 and now expects FY2026 organic revenue growth of around 2%, while maintaining profit expectations and continuing portfolio reshaping.

Smiths Group finalises DRC Heat Transfer purchase to strengthen Flex-Tek

Smiths has completed its acquisition of DRC Heat Transfer, adding complementary thermal products and solutions to Flex-Tek and strengthening its position in growing markets such as backup power and mission-critical applications.

Smiths Group advances strategy with asset sales and strong H1 performance

Smiths Group reports solid first-half growth and margin improvement, alongside major disposals and a new £1.5bn capital return programme, as it focuses on higher-growth engineering markets.

Smiths to acquire DRC Heat Transfer to expand data centre capabilities

Smiths has agreed to acquire US-based DRC Heat Transfer for £164m, strengthening Flex-Tek’s industrial heat business and expanding its cooling and power generation solutions for data centres and other mission-critical markets.

Smiths Group to sell Smiths Interconnect to Molex for £1.3 billion

Smiths Group plc has agreed to sell Smiths Interconnect to Molex Electronic Technologies Holdings, LLC, a Koch company, for an enterprise value of £1.3 billion, equivalent to 15.1 times FY2025 EBITDA.

    Search